rxstat › Shortages › Hepatitis B Surface Antigen Hepatitis A Virus / Inactivated
Hepatitis B Surface Antigen Hepatitis A Virus / Inactivated shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Hepatitis B Surface Antigen Hepatitis A Virus / Inactivated products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 15, 2026.
In shortage since
May 15, 2026
Est. full return
Jun 15, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTWINRIX JUNIOR
10MCG
360UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · since May 15, 2026, est. end Jun 15, 2026 · Delay in shipping of the drug.
ResolvedTWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended Dec 8, 2022 · Delay in shipping of the drug.
ResolvedTWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Mar 24, 2020 · Delay in shipping of the drug.
ResolvedTWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Oct 21, 2019 · Disruption of the manufacture of the drug.
ResolvedTWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended May 10, 2019 · Demand increase for the drug.
ResolvedTWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Mar 14, 2019 · Demand increase for the drug.
ResolvedTWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended Feb 6, 2019 · Demand increase for the drug.
ResolvedTWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Jan 17, 2018 · Demand increase for the drug.
ResolvedTWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended Dec 4, 2017 · Demand increase for the drug.
ResolvedTWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Dec 4, 2017 · Delay in shipping of the drug.
ResolvedTWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended Oct 10, 2017 · Delay in shipping of the drug.
ResolvedTWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Jul 10, 2017 · Demand increase for the drug.
What's happening
Hepatitis B Surface Antigen Hepatitis A Virus / Inactivated is currently affected by an active shortage report filed with Health Canada by GLAXOSMITHKLINE INC.
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Hepatitis B Surface Antigen Hepatitis A Virus / Inactivated is classified under “VIRAL VACCINES” (ATC J07BC).
Recent changes
Common questions
When will Hepatitis B Surface Antigen Hepatitis A Virus / Inactivated be back in stock in Canada?
The latest manufacturer estimate is Jun 15, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Hepatitis B Surface Antigen Hepatitis A Virus / Inactivated in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.